Amiodarone Induced Hyponatremia Masquerading as Syndrome of Inappropriate Antidiuretic Hormone Secretion by Anaplastic Carcinoma of Prostate
Author(s) -
Pinaki Dutta,
Girish Parthan,
Anuradha Aggarwal,
Santosh Kumar,
Nandita Kakkar,
Anil Bhansali,
Fabio Rotondo,
Kálmán Kovács
Publication year - 2014
Publication title -
case reports in urology
Language(s) - English
Resource type - Journals
eISSN - 2090-696X
pISSN - 2090-6978
DOI - 10.1155/2014/136984
Subject(s) - medicine , amiodarone , hyponatremia , syndrome of inappropriate antidiuretic hormone secretion , malignancy , etiology , pathology , hormone , antidiuretic , atrial fibrillation
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is one of the most common causes of hyponatremia. The usual causes are malignancies, central nervous system, pulmonary disorders, and drugs. Amiodarone is a broad spectrum antiarrhythmic agent widely used in the management of arrhythmias. The different side effects include thyroid dysfunction, visual disturbances, pulmonary infiltrates, ataxia, cardiac conduction abnormalities, drug interactions, corneal microdeposits, skin rashes, and gastrointestinal disturbances. SIADH is a rare but lethal side effect of amiodarone. We describe a 62-year-old male who was suffering from advanced prostatic malignancy, taking amiodarone for underlying heart disease. He developed SIADH which was initially thought to be paraneoplastic in etiology, but later histopathology refuted that. This case emphasizes the importance of detailed drug history and the role of immunohistochemistry in establishing the diagnosis and management of hyponatremia due to SIADH.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom